Northern Trust’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-190,420
| Closed | -$1.89M | – | 4665 |
|
|
2023
Q1 | $1.89M | Sell |
190,420
-6,169
| -3% | -$61.1K | ﹤0.01% | 2966 |
|
|
2022
Q4 | $1.96M | Buy |
196,589
+3,585
| +2% | +$26.7K | ﹤0.01% | 3004 |
|
|
2022
Q3 | $1.06M | Buy |
193,004
+12,399
| +7% | +$68.8K | ﹤0.01% | 3295 |
|
|
2022
Q2 | $660K | Buy |
180,605
+1,228
| +0.7% | +$5.8K | ﹤0.01% | 3457 |
|
|
2022
Q1 | $1.08M | Sell |
179,377
-3,246
| -2% | -$19.8K | ﹤0.01% | 3380 |
|
|
2021
Q4 | $1.54M | Buy |
182,623
+18,354
| +11% | +$160K | ﹤0.01% | 3355 |
|
|
2021
Q3 | $1.49M | Buy |
164,269
+10,446
| +7% | +$89.8K | ﹤0.01% | 3409 |
|
|
2021
Q2 | $1.25M | Sell |
153,823
-5,891
| -4% | -$40.4K | ﹤0.01% | 3478 |
|
|
2021
Q1 | $880K | Sell |
159,714
-89,257
| -36% | -$441K | ﹤0.01% | 3635 |
|
|
2020
Q4 | $847K | Sell |
248,971
-33,786
| -12% | -$89K | ﹤0.01% | 3578 |
|
|
2020
Q3 | $478K | Buy |
282,757
+110,450
| +64% | +$167K | ﹤0.01% | 3622 |
|
|
2020
Q2 | $281K | Buy |
172,307
+147,969
| +608% | +$294K | ﹤0.01% | 3678 |
|
|
2020
Q1 | $47K | Hold |
24,338
| – | – | ﹤0.01% | 3965 |
|
|
2019
Q4 | $69K | Sell |
24,338
-1,327
| -5% | -$3.84K | ﹤0.01% | 4009 |
|
|
2019
Q3 | $84K | Hold |
25,665
| – | – | ﹤0.01% | 3953 |
|
|
2019
Q2 | $83K | Hold |
25,665
| – | – | ﹤0.01% | 4000 |
|
|
2019
Q1 | $96K | Sell |
25,665
-4,398
| -15% | -$15.4K | ﹤0.01% | 3931 |
|
|
2018
Q4 | $104K | Hold |
30,063
| – | – | ﹤0.01% | 3913 |
|
|
2018
Q3 | $216K | Buy |
30,063
+15,878
| +112% | +$123K | ﹤0.01% | 3847 |
|
|
2018
Q2 | $99K | Sell |
14,185
-1,665
| -11% | -$10.4K | ﹤0.01% | 4020 |
|
|
2018
Q1 | $99K | Sell |
15,850
-2,649
| -14% | -$16.7K | ﹤0.01% | 3980 |
|
|
2017
Q4 | $104K | Sell |
18,499
-1,355
| -7% | -$6.17K | ﹤0.01% | 3962 |
|
|
2017
Q3 | $93K | Buy |
+19,854
| New | +$105K | ﹤0.01% | 3972 |
|
|
2015
Q2 | – | Sell |
-134
| Closed | -$26K | – | 4296 |
|
|
2015
Q1 | $26K | Hold |
134
| – | – | ﹤0.01% | 4208 |
|
|
2014
Q4 | $29K | Hold |
134
| – | – | ﹤0.01% | 4155 |
|
|
2014
Q3 | $36K | Sell |
134
-1
| -0.7% | -$272 | ﹤0.01% | 4179 |
|
|
2014
Q2 | $41K | Buy |
135
+3
| +2% | +$952 | ﹤0.01% | 4129 |
|
|
2014
Q1 | $48K | Buy |
+132
| New | +$47.9K | ﹤0.01% | 4061 |
|
Northern Trust's APEN Position: Q2 2023 in Review
Northern Trust sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 190,420 shares — an estimated $1.89M sold.
Northern Trust first reported a position in APEN in Q1 2014 and held it in 28 quarters. The position peaked at $1.96M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Northern Trust reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Northern Trust sold 190,420 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $1.89M.
- Northern Trust first reported a position in Apollo Endosurgery, Inc. in Q1 2014 and held it in 28 quarters.
- Northern Trust's Apollo Endosurgery, Inc. position peaked at $1.96M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.